Diagnostics News and Research

RSS

UA researchers awarded NIH grant to develop software that lets doctors analyze digitized biomedical data

The National Institutes of Health has awarded a $1.3 million grant to researchers at the University of Arizona to develop open-source software that will enable health care professionals and scientists to manage biomedical big data in digital form.

10 Jul 2015

Tillotts Pharma to purchase global rights for AstraZeneca’s Entocort excluding the U.S.

Tillotts Pharma AG, part of the Zeria Group, announced today that it has entered into an agreement for the acquisition of the global rights for Entocort (budesonide) from AstraZeneca, excluding the U.S., which will remain with AstraZeneca.

9 Jul 2015

Isis Innovation, Ludwig Cancer Research announce launch of new cancer immunotherapy spinout

Isis Innovation, the University of Oxford's technology commercialisation company, and Ludwig Cancer Research are proud to announce the launch of a new spinout company, iOx Therapeutics. iOx Therapeutics will develop a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford's Weatherall Institute of Molecular Medicine.

9 Jul 2015

Sorrento, NantBioScience form joint venture to develop targeted therapies against cancer

Sorrento Therapeutics, Inc. and NantBioScience, Inc., a majority owned subsidiary of NantWorks, LLC, announced today that they have established a joint venture to focus on the development of 'first-in-class' small molecules against targets that have eluded the pharmaceutical industry to date and which may address important drivers of cancer growth including cancer stem cells.

9 Jul 2015

Ludwig, CRI launch clinical trials to evaluate immunotherapies for treatment of GBM and solid tumors

Ludwig Cancer Research and the Cancer Research Institute have launched clinical trials evaluating an immunotherapy for the treatment of the brain cancer glioblastoma multiforme (GBM), and a combination of immunotherapies for a variety of solid tumors.

8 Jul 2015

ImmunID announces publication of clinical study data on ImmunTraCkeR assay in the Journal for ImmunoTherapy of Cancer

ImmunID today announced the publication of a short report in the Journal for ImmunoTherapy of Cancer showing that the analysis of peripheral T cell receptor diversity using the company's ImmunTraCkeR assay is associated with clinical outcomes following Ipilimumab treatment in metastatic melanoma.

8 Jul 2015

Study aims to determine utility of Trovagene's PCM technology for predicting response to cancer immunotherapy

Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced the launch of a study that aims to determine utility of the Company's Precision Cancer Monitoring (PCM) technology for predicting response to treatment in advanced melanoma patients receiving one or a combination of the novel immunotherapy agents Yervoy (ipilumumab), a CTLA-4 inhibitor, and Opdivo (nivolumab), a PD-1 inhibitor.

8 Jul 2015

Mindray announces definitive agreement to acquire remaining stake in Dragonbio for US$72.6 million

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitive agreement to acquire the remaining stake in Wuhan Dragonbio Surgical Implant Co., Ltd. for approximately US$72.6 million.

From Mindray 7 Jul 2015

Academics call for more research to understand hospital weekend death risk

Two academics from the University of Warwick say more research is needed to understand why patients are more likely to die in hospital at the weekend.

7 Jul 2015

Transitioning Infrared Imaging into Clinical Use

The CLIRSPEC network is a UK Engineering and Physical Sciences Research Council (EPSRC – EP/L012952/1) funded network in clinical infrared and Raman spectroscopy. Infrared and Raman spectroscopy can identify the hallmarks of disease and distinguish between diseased and non-diseased samples based upon inherent chemistry.

From Daylight Solutions Inc 7 Jul 2015

INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute

Following the launch of its limited edition PIPETGIRL pink pipette controller in support of breast cancer research earlier this year - INTEGRA is pleased to announce it has made a $10,000 contribution to the Susan F Smith Center for Womens Cancers at the Dana-Farber Cancer Institute in Boston (MA, USA).

From INTEGRA Biosciences 6 Jul 2015

New treatment option available for CLL patients in Manitoba and Saskatchewan

People in Manitoba and Saskatchewan living with Chronic Lymphocytic Leukemia (CLL) will now be able to access a new treatment option through the prescription drug insurance plans in both provinces. Earlier this week, GAZYVA (obinutuzumab) in combination with chlorambucil chemotherapy was added to benefits formularies of the Provincial Oncology Drug Programs at CancerCare Manitoba and the Saskatchewan Cancer Agency.

6 Jul 2015

Konica Minolta announces acquisition of Sawae Technologica

Konica Minolta, Inc. today announced that it has acquired Sawae Technologica Ltda., an X-ray system equipment manufacturer based in Minas Gerais, Brazil, through its Brazilian healthcare sales company, Konica Minolta Healthcare do Brazil.

2 Jul 2015

ALPINION launches new E-CUBE Series ultrasound system

ALPINION MEDICAL SYSTEMS Co., Ltd., announced today the launch of a new E-CUBE Series ultrasound system. Developed to enhance user experience and patient care in a range of clinical areas, the E-CUBE 15 EX produces superb image quality. With advanced imaging technologies, this system delivers outstanding clinical performance in women's health, general imaging, and shared service applications.

2 Jul 2015

ADAMAAS project focuses on developing mobile assistance system that supports users in everyday situations

A new research project at the Cluster of Excellence Cognitive Interactive Technology in Bielefeld University focuses on the development of a mobile adaptive assistance system in the form of intelligent glasses that provide unobtrusive and intuitive support in everyday situations. The technology platform is being provided by eye tracking specialist SensoMotoric Instruments.

2 Jul 2015

Spectrum Health Innovations inks licensing agreement with Min-Bio to manufacture trauma surgery basin

Spectrum Health Innovations has signed a licensing agreement with Min-Bio, LLC, of Lowell, Mich. to manufacture a new trauma surgery basin that is a cut above existing designs.

2 Jul 2015

UVA Health System opens high-tech clinical genomics lab

The University of Virginia Health System has opened a high-tech clinical genomics lab that will personalize care for patients, help doctors determine the best treatments for cancers and other diseases, and allow UVA to offer the most cutting-edge clinical trials.

1 Jul 2015

UNSW Australia to co-host sixth International Nanomedicine Conference in Sydney

Advances in nanotechnology and nano-fabrication are fundamentally changing the future of medicine, enabling more effective diagnostics and targeted drugs, and new bioactive materials that can help repair our bodies.

1 Jul 2015

Nuclea and Aelan partner to develop, commercialize novel biomarker tests using STEM cells as models

Nuclea Biotechnologies Inc. announced today that it is partnering with Aelan Cell Technologies Inc. (San Francisco, California) for the development, validation and commercialization of novel biomarker tests and companion diagnostics using human STEM cells as models.

1 Jul 2015

Roswell Park, Lakeshore Cancer Center partner to improve access to cancer care for Nigerians

America's oldest cancer center and one of the world's newest oncology centers are partnering to improve access to cancer prevention, screening and care for the people of Nigeria. Roswell Park Cancer Institute and Lakeshore Cancer Center have announced an affiliation that will see Roswell Park faculty providing clinical consultations to assist LCC oncologists, who will also have access to both training at RPCI and continuing professional education seminars they can participate in remotely.

1 Jul 2015

Diagnostics News and Research

UA researchers awarded NIH grant to develop software that lets doctors analyze digitized biomedical data

Tillotts Pharma to purchase global rights for AstraZeneca’s Entocort excluding the U.S.

Isis Innovation, Ludwig Cancer Research announce launch of new cancer immunotherapy spinout

Sorrento, NantBioScience form joint venture to develop targeted therapies against cancer

Ludwig, CRI launch clinical trials to evaluate immunotherapies for treatment of GBM and solid tumors

ImmunID announces publication of clinical study data on ImmunTraCkeR assay in the Journal for ImmunoTherapy of Cancer

Study aims to determine utility of Trovagene's PCM technology for predicting response to cancer immunotherapy

Mindray announces definitive agreement to acquire remaining stake in Dragonbio for US$72.6 million

Academics call for more research to understand hospital weekend death risk

Transitioning Infrared Imaging into Clinical Use

INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute

New treatment option available for CLL patients in Manitoba and Saskatchewan

Konica Minolta announces acquisition of Sawae Technologica

ALPINION launches new E-CUBE Series ultrasound system

ADAMAAS project focuses on developing mobile assistance system that supports users in everyday situations

Spectrum Health Innovations inks licensing agreement with Min-Bio to manufacture trauma surgery basin

UVA Health System opens high-tech clinical genomics lab

UNSW Australia to co-host sixth International Nanomedicine Conference in Sydney

Nuclea and Aelan partner to develop, commercialize novel biomarker tests using STEM cells as models

Roswell Park, Lakeshore Cancer Center partner to improve access to cancer care for Nigerians

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News